Medley Nears Completion of ¥3 Billion Share Buyback Program

An update from Medley ( (JP:4480) ) is now available.

Medley, Inc. reported progress on its ongoing share repurchase program authorized by its board in November 2025, detailing that it bought back 840,100 common shares on the Tokyo Stock Exchange between February 1 and February 28, 2026, for a total of about ¥1.67 billion. Under the broader authorization to repurchase up to 1.5 million shares or ¥3 billion by March 31, 2026, the company has, as of February 28, acquired a total of 1,369,200 shares for roughly ¥2.96 billion, signaling an active capital return policy and potentially supporting its share price and capital efficiency metrics.

The buyback execution indicates management’s willingness to deploy a substantial portion of the approved repurchase capacity within a relatively short timeframe. This move may enhance earnings per share through a reduced share count and underscores the company’s confidence in its business outlook, with implications for existing shareholders in terms of both ownership concentration and perceived valuation support.

The most recent analyst rating on (JP:4480) stock is a Sell with a Yen1794.00 price target. To see the full list of analyst forecasts on Medley stock, see the JP:4480 Stock Forecast page.

More about Medley

Medley, Inc. is a Japan-based company listed on the Tokyo Stock Exchange Prime Market that operates in the digital and healthcare-related services sector. It provides technology-driven solutions and platforms, with a focus on medical and human resources fields, positioning itself as a growth-oriented player in Japan’s healthcare and HR technology markets.

YTD Price Performance: -15.83%

Average Trading Volume: 316,389

Technical Sentiment Signal: Sell

Current Market Cap: Yen64.95B

For a thorough assessment of 4480 stock, go to TipRanks’ Stock Analysis page.